Malaysian Genomics Resource Centre Berhad (KLSE: MGRC)
Health Care · Life Sciences Tools & Services · MY
RM0.35
-2.78% today · +70.7% 1Y
Malaysian Genomics Resource Centre Berhad (KLSE: MGRC) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $12.93M.
Over the last twelve months the share price has gained 70.7%, trading between 0.16 and 0.39.
Tweenvest scores Malaysian Genomics Resource Centre Berhad across four factors: quality 60/100, value 22/100, growth 100/100. Its strongest factor is growth.
MGRC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.93M
- Revenue (TTM)
- $2.47M
- P/E
- 94.01
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 0.15
- 52-week high
- RM0.39
- 52-week low
- RM0.16
- Avg volume (3M)
- —
- Shares outstanding
- 150.93M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bionano Genomics, Inc.NasdaqCM: BNGO | $16.90M | $1.44 | -1.71% |
| Fusion Antibodies plcAIM: FAB | $16.56M | £0.10 | -11.11% |
| Proteomics International Laboratories LtdASX: PIQ | $14.43M | AU$0.13 | +4.17% |
| Genetic Signatures LimitedASX: GSS | $13.31M | AU$0.08 | +6.33% |
| Welgene Biotech Co.,Ltd.TPEX: 6661 | $12.58M | NT$17.20 | +6.17% |
| Pharma-Bio Serv, Inc.OTCPK: PBSV | $10.99M | $0.48 | -4.00% |
| Memphasys LimitedASX: MEM | $10.77M | AU$0.01 | -16.67% |
| China Health Group Inc.SEHK: 8225 | $10.02M | HK$0.08 | +12.86% |
Figures last refreshed Oct 11, 2026.